Trademarkia Logo

Canada

C$
MAPS TECHNOLOGY
FORMALIZED

on 9 May 2025

Last Applicant/ Owned by

Affinivax, Inc.

Corporation Service Company251 Little Falls DriveWilmington, DE 19808

US

Serial Number

2397886 filed on 9th May 2025

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

CA

H3B1R1

MAPS TECHNOLOGY

Trademark usage description

human vaccines; human vaccines for the prophylaxis and treatment of infectious diseases and cancer; human vaccines, namely, immunotherapies for the tr Read More

Classification Information


Class [005]
Human Vaccines; human vaccines for the prophylaxis and treatment of infectious diseases and cancer; human vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; human vaccines comprising polysaccharide antigens and protein-based antigens; human vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens; none of the foregoing vaccines being administered by micro array patch, transdermal patch or oral thin film


Classification kind code

12

Class [042]
Research and development services in the field of vaccines; research and development services in the field of vaccines for the prophylaxis and treatment of infectious diseases and cancer; research and development services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; research and development in the field of vaccines comprising polysaccharide antigens and protein based antigens; research and development in the field of vaccines, namely, immunotherapies comprising polysaccharide antigens and protein-based antigens, none of the foregoing relating to micro array patches, transdermal patches, or oral thin films


Classification kind code

12

Mark Details


Serial Number

2397886

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 30
on 9th May 2025
Filed
Submitted for opposition 1
on 9th May 2025
Created
Submitted for opposition 31
on 9th May 2025
Formalized